SAG
SageView Advisory Group’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
9,225
+2,425
| +36% | +$274K | 0.04% | 234 |
|
|
2025
Q1 | $762K | Sell |
6,800
-377
| -5% | -$42.2K | 0.03% | 266 |
|
|
2024
Q4 | $663K | Sell |
7,177
-369
| -5% | -$34.1K | 0.03% | 293 |
|
|
2024
Q3 | $633K | Sell |
7,546
-1,071
| -12% | -$89.8K | 0.03% | 259 |
|
|
2024
Q2 | $591K | Buy |
+8,617
| New | +$591K | 0.03% | 307 |
|
|
2024
Q1 | – | Sell |
-20,719
| Closed | -$1.63M | – | 609 |
|
|
2023
Q4 | $1.63M | Buy |
20,719
+1,791
| +9% | +$141K | 0.07% | 178 |
|
|
2023
Q3 | $1.42M | Sell |
18,928
-74
| -0.4% | -$5.55K | 0.08% | 159 |
|
|
2023
Q2 | $1.46M | Buy |
19,002
+752
| +4% | +$58K | 0.08% | 165 |
|
|
2023
Q1 | $1.51M | Buy |
18,250
+13,632
| +295% | +$1.13M | 0.1% | 140 |
|
|
2022
Q4 | $396K | Buy |
+4,618
| New | +$396K | 0.03% | 276 |
|